DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Active ingredient: Tioconazole - Brands, Medical Use, Clinical Data

Brands, Medical Use, Clinical Data

Drug Category

  • Antifungal Agents

Dosage Forms

  • Cream
  • Ointment
  • Suppository (each applicator-full provides approximately 4.6 grams of ointment containing 300 mg of tioconazole)

Brands / Synonyms

Fungibacid; GyneCure; GyneCure Ovules; GyneCure Vaginal Ointment Tandempak; GyneCure Vaginal Ovules Tandempak; Gyno-trosyd; Monistat 1; Oxiconazolc Nitrate; Oxiconazole; Oxiconazole nitrate; Thioconazole; Tioconazol [INN-Spanish]; Tioconazole [USAN:BAN:INN:JAN]; Tioconazolum [INN-Latin]; Trosyd; Trosyd AF; Trosyd J; Trosyl; Tz-3; Vagistat; Vagistat-1; Zoniden

Indications

For the local treatment of vulvovaginal candidiasis (moniliasis).

Pharmacology

Tioconazole is a broad-spectrum imidazole antifungal agent that inhibits the growth of human pathogenic yeasts. Tioconazole exhibits fungicidal activity in vitro against Candida albicans, other species of the genus Candida, and against Torulopsis glabrata. Tioconazole prevents the growth and function of some fungal organisms by interfering with the production of substances needed to preserve the cell membrane. This drug is effective only for infections caused by fungal organisms. It will not work for bacterial or viral infections.

Mechanism of Action

Tioconazole interacts with 14-α demethylase, a cytochrome P-450 enzyme that converts lanosterol to ergosterol, an essential component of the yeast membrane. In this way, tioconazole inhibits ergosterol synthesis, resulting in increased cellular permeability. Tioconazole may also inhibit endogenous respiration, interact with membrane phospholipids, inhibit the transformation of yeasts to mycelial forms and the uptake of purine, impair triglyceride and/or phospholipid biosynthesis, and inhibit the movement of calcium and potassium ions across the cell membrane by blocking the ion transport pathway known as the Gardos channel.

Absorption

Systemic absorption following a single intravaginal application of tioconazole in nonpregnant patients is negligible.

Toxicity

Symptoms of overdose include erythema, stinging, blistering, peeling, edema, pruritus, urticaria, burning, and general irritation of the skin, and cramps.

Biotrnasformation / Drug Metabolism

Orally administered tioconazole is extensively metabolized. The major metabolites are glucuronide conjugates.

Contraindications

VAGISTAT-1 is contraindicated in individuals who have been shown to be sensitive to imidazole antifungal agents or to other components of the ointment.

Drug Interactions

Not Available

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012